Skip to content

Influence of Oxygen Target Range on Intermittent Hypoxemia in Preterm Infants

Influence of Oxygen Target Range on Intermittent Hypoxemia in Preterm Infants

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02743988
Enrollment
36
Registered
2016-04-19
Start date
2015-05-31
Completion date
2017-09-30
Last updated
2016-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Apnea of Prematurity, Intermittent Hypoxemia

Keywords

cerebral oxygenation, NIRS, near-infrared spectroscopy, bradycardia, hypoxemia, cerebral perfusion, cardiac output, apnea, desaturation, oxygen saturation target range

Brief summary

In this randomized crossover trial, preterm infants with intermittent hypoxemia and need for supplemental oxygen will be randomized to either Sequence of two different oxygen target ranges (low: 85-89%; high: 91-95%) for a total duration of 19 hours. Cerebral oxygenation, cardiac output, arterial oxygenation and heart rate will be measured continuously. Primary outcome is time with arterial oxygen saturation \< 80%.

Interventions

DRUGOxygen

Adapt inspired oxygen to achieve desired SpO2 target range

Sponsors

University of Ulm
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Days to 42 Days
Healthy volunteers
No

Inclusion criteria

* preterm infant \< 29 weeks gestation * at least 8 hypoxemic events during 8 hours * requires supplemental oxygen to achieve high SpO2 target range * parental consent given

Exclusion criteria

* congenital life-threatening malformation * fatal outcome expected * airway malformation * higher grade intraventricular bleeding (grade III or IV according to LA Papile) * posthaemorrhagic hydrocephalus * life-threatening disease at the time of study entry

Design outcomes

Primary

MeasureTime frame
Duration SpO2 < 80%during 16 hours of measurement

Secondary

MeasureTime frameDescription
Arterial SpO2 as measured by pulse oxymetryduring 16 hours of measurementArea under 80%
Heart rate as measured by ECGduring 16 hours of measurementArea under 80/min
cerebral and visceral fractional oxygen extraction as measured by NIRSduring 16 hours of measurement
Cerebral tissue oxygen saturation as measured by NIRSduring 16 hours of measurementArea under threshold
Number of hypoxemic and / or bradycardic eventsduring 16 hours of measurement
Visceral tissue oxygen saturation as measured by NIRSduring 16 hours of measurementArea under threshold
Cardiac output as measured by Cardiovelocimetryduring 16 hours of measurement

Countries

Germany

Contacts

Primary ContactManuel B Schmid, MD
manuel.schmid@uni-ulm.de+41762515201

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026